Please note the ANZCTR will be unattended from Friday 24 December 2021 for the holidays. The Registry will re-open on Monday 17 January 2022. Submissions and updates will not be processed during that time.

For new and updated trial submissions, we are processing trials as quickly as possible and appreciate your patience. We recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR

Registration number
Ethics application status
Date submitted
Date registered
Date last updated
Type of registration
Retrospectively registered

Titles & IDs
Public title
Effect on Hospitalisation and Cost Effectiveness of a Respiratory Coordinated Care Program for patients with Chronic Obstructive Pulmonary Disease.
Scientific title
A study of COPD Patients undergoing a Respiratory Coordinated Care Program and its effect on hospitalisation and cost for the 12 months before and after joining the program.
Secondary ID [1] 287503 0
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
COPD 296259 0
Condition category
Condition code
Respiratory 296529 296529 0 0
Chronic obstructive pulmonary disease
Public Health 296635 296635 0 0

Study type
Description of intervention(s) / exposure
The intervention is a Respiratory Coordinated Care Program. This is a multidisciplinary program for chronic respiratory disease patients involving regular outpatient follow ups by nurse specialists with liaison with physiotherapists, occupational therapists, respiratory registrars and consultants. These visits involve one on one home visits, initially weekly, then fortnightly and then monthly at the discretion of the treating nurse and team. At each visit, the patient's clinical state is assessed, as well as compliance with treatment, equipment supply and patient understanding of proper usage e.g. inhaler and spacer technique, referral to pulmonary rehabilitation as needed, and recognition of early clinical deterioration prompting an action plan whereby the community nurse would directly contact a respiratory physician or senior registrar, and early community treatment such as antibiotics, bronchodilators and steroids could be implemented. The service also provides close follow up of patients post discharge from hospital in order to facilitate ongoing recovery from their illness, and allow more rapid discharge from hospital. Missed visits are followed up with phone calls.
Intervention code [1] 292890 0
Treatment: Other
Comparator / control treatment
The comparator treatment is the standard of care for COPD patients involving GP and respiratory physician follow ups on an individually determined basis. As this was not a randomised study, the comparator treatment was determined by the care patients received prior to joining the intervention.
Control group

Primary outcome [1] 296155 0
Hospitalisation rate
- measured by using hospital and database records for number of hospitalisations and length of stay in 12 month period
Timepoint [1] 296155 0
12 months
Secondary outcome [1] 317648 0
Cost to hospital
- simple cost analysis of costs of program including staff salaries, motor vehicle costs, medications and medical equipment, and calculating a cost of the program per patient. This was offset against savings made from changes in hospital admission rates and bed days, with 1 hospital bed day of a COPD admission conservatively estimated at $AUD 568 ($USD 400) based on the available literature
Timepoint [1] 317648 0
12 months

Key inclusion criteria
COPD by GOLD criteria, FEV1 < 50% predicted, Age greater than or equal to 60, psychosocial stability
Minimum age
60 Years
Maximum age
No limit
Both males and females
Can healthy volunteers participate?
Key exclusion criteria
other primary respiratory diagnosis

Study design
Purpose of the study
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Not randomised, all patients in the study are enrolled in the program.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?

Intervention assignment
Single group
Other design features
Not Applicable
Type of endpoint(s)
Statistical methods / analysis
The intervention and comparator groups were compared using paired t-test and multiple regression analysis to address the impact of confounding factors. No power calculations have been performed.

Recruitment status
Date of first participant enrolment
Date of last participant enrolment
Date of last data collection
Sample size
Accrual to date
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 4367 0
St George Hospital - Kogarah
Recruitment hospital [2] 4368 0
The Sutherland Hospital - Caringbah
Recruitment postcode(s) [1] 10592 0
2217 - Kogarah
Recruitment postcode(s) [2] 10593 0
2232 - Sutherland

Funding & Sponsors
Funding source category [1] 292079 0
Self funded/Unfunded
Name [1] 292079 0
Address [1] 292079 0
Country [1] 292079 0
Primary sponsor type
Respiratory Department St George Hospital
St George Hospital, Gray St, Kogarah, NSW, 2217
Secondary sponsor category [1] 290755 0
Name [1] 290755 0
Address [1] 290755 0
Country [1] 290755 0

Ethics approval
Ethics application status
Ethics committee name [1] 293561 0
Ethics committee address [1] 293561 0
St George Hospital
Gray St, Kogarah, NSW, Australia 2217
Ethics committee country [1] 293561 0
Date submitted for ethics approval [1] 293561 0
Approval date [1] 293561 0
Ethics approval number [1] 293561 0

Brief summary
COPD patients were enrolled into an RCCP coordinated multidisciplinary program aimed at improving health outcomes and decreasing hospitalisation. Data from 2007-2012 was prospectively collected in a database, and retrospectively reviewed. Patients were analysed as to rates of hospitalisation in the 12 months prior to and after joining the program. The cost of the program was analysed against savings from decreased hospitalisation.
Trial website
Trial related presentations / publications
Poster presentation
Aslam P., Man J., Behary J., Riskallah J., Ansary S., Kwan B., "Outcomes and Cost of COPD RCCP Program", Thoracic Society of Australia and New Zealand Respiratory Education Meeting November 15, 2013

Public notes
Ethics approval was obtained after enrollment in the intervention study was complete, as although data was prospectively collected, the intervention was set up in its own right, and it was unclear if a study was to be formally performed on the collected data. When a decision was made that the data was to be retrospectively analysed in a study, ethics approval was then sought and obtained, and data analysis then occurred.

Principal investigator
Name 60466 0
Dr Johnathan Man
Address 60466 0
Department of Respiratory Medicine
Sutherland Hospital
Kingsway, Caringbah, NSW 2229
Country 60466 0
Phone 60466 0
Fax 60466 0
Email 60466 0
Contact person for public queries
Name 60467 0
Dr Benjamin Kwan
Address 60467 0
Department of Respiratory Medicine
Sutherland Hospital
Kingsway, Caringbah, NSW 2229
Country 60467 0
Phone 60467 0
+61 2 95407111
Fax 60467 0
Email 60467 0
Contact person for scientific queries
Name 60468 0
Dr Benjamin Kwan
Address 60468 0
Department of Respiratory Medicine
Sutherland Hospital
Kingsway, Caringbah, NSW 2229
Country 60468 0
Phone 60468 0
+61 2 95407111
Fax 60468 0
Email 60468 0

No information has been provided regarding IPD availability
Summary results
Have study results been published in a peer-reviewed journal?
Other publications
Have study results been made publicly available in another format?
Results – basic reporting
Results – plain English summary